SCO-Spondin Derived Peptide NX210 Induces Neuroprotection In Vitro and Promotes Fiber Regrowth and Functional Recovery after Spinal Cord Injury

PLoS ONE, 2014 · DOI: 10.1371/journal.pone.0093179 · Published: March 25, 2014

Simple Explanation

This study investigates NX210, a peptide derived from SCO-spondin, for its potential to protect nerve cells and promote recovery after spinal cord injury. SCO-spondin is a protein involved in the development of the nervous system. The researchers tested NX210 in lab-grown cells and in rats with spinal cord injuries. They looked at whether NX210 could protect cells from damage, help nerve fibers regrow, and improve overall function. The results showed that NX210 had a protective effect on nerve cells in the lab, promoted the regrowth of nerve fibers in one rat model of spinal cord injury, and improved functional recovery in another rat model.

Study Duration

10 days (neurite regrowth model), 30 days (functional recovery model)

Participants

Adult female Sprague-Dawley rats (240–300 g), B104 neuroblastoma cell line

Evidence Level

In vitro and in vivo experimental study

Key Findings

1
NX210 provides neuroprotection against oxidative stress in B104 neuroblastoma cells in vitro.
2
NX210 stimulates axonal regrowth in longitudinally oriented neofibers in an aspiration model of spinal cord injury in rats.
3
NX210 significantly improves functional recovery in a contusive model of spinal cord injury in rats, as measured by BBB scores and reflex testing.

Research Summary

This study evaluated the neuroprotective and neuroregenerative properties of NX210, a peptide derived from SCO-spondin, in vitro and in vivo for the treatment of spinal cord injury (SCI). In vitro studies demonstrated that NX210 provides neuroprotection to oxidative stress in B104 neuroblastoma cells. In vivo studies showed that NX210 stimulates axonal regrowth in longitudinally oriented neofibers in an aspiration model of SCI and significantly improves functional recovery in a contusive model of SCI.

Practical Implications

Therapeutic Potential

NX210 could be a candidate molecule for the medical management of patients with spinal cord injury, warranting further investigation.

Neuroprotection Strategy

The neuroprotective property of NX210 demonstrated in vitro using B104 resistance to H2O2 suggests a potential strategy for reducing secondary injury mechanisms after SCI.

Regenerative Medicine

NX210's ability to promote axonal regrowth and improve functional recovery in animal models supports its potential role in regenerative medicine approaches for SCI.

Study Limitations

1
The BBB scale gives only a global assessment of spinal function.
2
Collateral sprouting from lesioned hindlimb corticospinal tract axons may contribute to functional improvement.
3
The anatomical substrate of the reflexes is not clearly understood.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury